Abhijeet Singh
Research Subjects
Research Interests
Abhijeet Singh has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Rajendra Prasad
Director of Medical Education and Head Pulmonary Medicine, Era's Lucknow Medical College and Hospital, Lucknow
5 shared publicationsViswesvaran Balasubramanian
Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India
4 shared publicationsNitesh Gupta
Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India
3 shared publications- Rajendra Prasad
Department of Horticulture, K.A.P.G. College, Prayagraj (U.P.) India
3 shared publications Ayush Gupta
Department of Pulmonary and Critical care medicine, Medeor JCS Institute of Pulmonary, Critical Care & Sleep Medicine, Qutab Institutional Area, New Delhi
2 shared publications- M. K. Sinha
Department of Mechanical Engineering, National Institute of Technology Jamshedpur, India
2 shared publications
Latest Publications
- 13 May 2021
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2341 (1) , 030021
Computational study on the dynamics of drop generation under different ambient conditions
This research paper explains the generation and evolution of a Newtonian fluid droplet through the computational simulation. The volume of fluid method is adopted to capture the dynamic mechanism of the droplet. The results show how the physical properties of the continuous phase affect the drop formation, breakup length and volume of droplet. The pressure variation at the detachment stages is also examined. Also, studies the difference in the vorticity distribution around the droplet generated in two different phase conditions.
- 13 May 2021
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2341 (1) , 030021
Computational study on the dynamics of drop generation under different ambient conditions
This research paper explains the generation and evolution of a Newtonian fluid droplet through the computational simulation. The volume of fluid method is adopted to capture the dynamic mechanism of the droplet. The results show how the physical properties of the continuous phase affect the drop formation, breakup length and volume of droplet. The pressure variation at the detachment stages is also examined. Also, studies the difference in the vorticity distribution around the droplet generated in two different phase conditions.
- Open Access
- 14 February 2021
- Published by Scientific Scholar in Annals of the National Academy of Medical Sciences (India)
- Vol. 57, 16-35
Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis
Drug-susceptible tuberculosis (DS-TB) requires treatment with first-line drugs (FLDs) whereas drug-resistant TB (DR-TB) are treated with combination of second-line drugs (SLDs) and fewer FLDs. Adverse drug reactions (ADRs) to these drugs are quite evident as they are being used for longer duration. The overall prevalence of ADRs with FLDs and SLDs are estimated to vary from 8.0 to 85 and 69 to 96%, respectively. Most ADRs are observed in the intensive phase as compared to continuation phase. Major concerns exist regarding treatment of DR-TB patients, especially with SLDs having lower efficacy more toxicity and high cost as compared to FLDs. A variety of ADRs may be produced by anti-TB drugs ranging from mild or minor to severe or major like gastrointestinal toxicity (nausea/vomiting, diarrhoea, and hepatotoxicity), ototoxicity, neurotoxicity (peripheral neuropathy and seizures), nephrotoxicity, cutaneous toxicity, and cardiotoxicity. Most of ADRs are minor and can be managed without discontinuation of treatment. Few ADRs' can be major causing life-threatening experience leading to either modification or discontinuation of regimen and even mortality. A careful monitoring of ADRs during the treatment with anti-TB drugs and early recognition and appropriate management of these ADRs might improve adherence leading to favorable outcome.
- 14 February 2021
- Published by Scientific Scholar in Annals of the National Academy of Medical Sciences (India)
- Vol. 57, 16-35
Open AccessAdverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis
Drug-susceptible tuberculosis (DS-TB) requires treatment with first-line drugs (FLDs) whereas drug-resistant TB (DR-TB) are treated with combination of second-line drugs (SLDs) and fewer FLDs. Adverse drug reactions (ADRs) to these drugs are quite evident as they are being used for longer duration. The overall prevalence of ADRs with FLDs and SLDs are estimated to vary from 8.0 to 85 and 69 to 96%, respectively. Most ADRs are observed in the intensive phase as compared to continuation phase. Major concerns exist regarding treatment of DR-TB patients, especially with SLDs having lower efficacy more toxicity and high cost as compared to FLDs. A variety of ADRs may be produced by anti-TB drugs ranging from mild or minor to severe or major like gastrointestinal toxicity (nausea/vomiting, diarrhoea, and hepatotoxicity), ototoxicity, neurotoxicity (peripheral neuropathy and seizures), nephrotoxicity, cutaneous toxicity, and cardiotoxicity. Most of ADRs are minor and can be managed without discontinuation of treatment. Few ADRs' can be major causing life-threatening experience leading to either modification or discontinuation of regimen and even mortality. A careful monitoring of ADRs during the treatment with anti-TB drugs and early recognition and appropriate management of these ADRs might improve adherence leading to favorable outcome.
- Open Access
- 12 August 2020
- Published by Springer Nature in Research Square
Severe Acute Respiratory Syndrome Coronavirus-2 and Pulmonary Tuberculosis Coinfection: Double Trouble
Background: The ongoing pandemic of novel coronavirus disease 2019 (COVID-19) has received worldwide attention by becoming a major global health threat. We encountered one case with COVID-19 and tuberculosis (TB) coinfection which has not been frequently reported. Case presentation: A 76 year old female presented with acute respiratory symptoms superimposed on chronic symptoms, suggestive to have pneumonia. Oropharyngeal throat swab sample for COVID-19 was positive as detected by real-time reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay. GeneXpert Ultra detected Mycobacterium tuberculosis complex with Rifampicin resistance indeterminate. Patient was treated with appropriate management. Conclusion: Clinicians should suspect coinfection with TB during ongoing pandemic of COVID-19 as therapeutic strategies need to be determined timely to improve outcome and prevent transmission in community.
- 12 August 2020
- Published by Springer Nature in Research Square
Open AccessSevere Acute Respiratory Syndrome Coronavirus-2 and Pulmonary Tuberculosis Coinfection: Double Trouble
Background: The ongoing pandemic of novel coronavirus disease 2019 (COVID-19) has received worldwide attention by becoming a major global health threat. We encountered one case with COVID-19 and tuberculosis (TB) coinfection which has not been frequently reported. Case presentation: A 76 year old female presented with acute respiratory symptoms superimposed on chronic symptoms, suggestive to have pneumonia. Oropharyngeal throat swab sample for COVID-19 was positive as detected by real-time reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay. GeneXpert Ultra detected Mycobacterium tuberculosis complex with Rifampicin resistance indeterminate. Patient was treated with appropriate management. Conclusion: Clinicians should suspect coinfection with TB during ongoing pandemic of COVID-19 as therapeutic strategies need to be determined timely to improve outcome and prevent transmission in community.
- 18 July 2020
- Published by Elsevier in Computers & Fluids
- Vol. 210, 104673
Investigation of drop's instability under different transition stages on axisymmetric flow model
- 18 July 2020
- Published by Elsevier in Computers & Fluids
- Vol. 210, 104673
Investigation of drop's instability under different transition stages on axisymmetric flow model
- Open Access
- 10 July 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (3) , 441-450
Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal
Disease associated with SARS-CoV-2 also termed as Coronavirus disease 2019 or COVID-19, has become a potential threat to public health by spreading across more than 200 countries worldwide within a short span of time. Tuberculosis (TB) is already existing as unprecedented pandemic worldwide over several years. Both diseases have many overlapping features but there are striking differences too. There is usually chronicity of symptoms in TB as compared to acute or rapid progression in COVID-19. Little evidence exists regarding TB and COVID-19 coinfection. It is anticipated that person with TB either in active, previously treated or latent forms are more at risk of poor outcomes with COVID-19. The relationship between the two diseases is still unclear at present, and more studies are needed to enable analyses of interactions and determinants of outcomes in patients affected by both the diseases. Most of the countries across the world imposed nationwide lockdown to promote social distancing, which is one important preventive measure to mitigate the spread of COVID-19 pandemic. However, it becomes quite challenging to ensure smooth functioning of programmatic services, leading to disruption of routine TB care, leading to transmission of infection. Health authorities should frame polices that can support TB patients by providing diagnostic, management and prevention services without any interruption during this era of ongoing COVID-19 pandemic. Effort should be made to control both the diseases simultaneously and avoid unfavourable outcome in near future.
- 10 July 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (3) , 441-450
Open AccessSevere acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal
Disease associated with SARS-CoV-2 also termed as Coronavirus disease 2019 or COVID-19, has become a potential threat to public health by spreading across more than 200 countries worldwide within a short span of time. Tuberculosis (TB) is already existing as unprecedented pandemic worldwide over several years. Both diseases have many overlapping features but there are striking differences too. There is usually chronicity of symptoms in TB as compared to acute or rapid progression in COVID-19. Little evidence exists regarding TB and COVID-19 coinfection. It is anticipated that person with TB either in active, previously treated or latent forms are more at risk of poor outcomes with COVID-19. The relationship between the two diseases is still unclear at present, and more studies are needed to enable analyses of interactions and determinants of outcomes in patients affected by both the diseases. Most of the countries across the world imposed nationwide lockdown to promote social distancing, which is one important preventive measure to mitigate the spread of COVID-19 pandemic. However, it becomes quite challenging to ensure smooth functioning of programmatic services, leading to disruption of routine TB care, leading to transmission of infection. Health authorities should frame polices that can support TB patients by providing diagnostic, management and prevention services without any interruption during this era of ongoing COVID-19 pandemic. Effort should be made to control both the diseases simultaneously and avoid unfavourable outcome in near future.
- Open Access
- 13 February 2019
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 13 (1) , 1-5
Role of bronchoscopy in diagnosis of smear-negative pulmonary tuberculosis
- 13 February 2019
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 13 (1) , 1-5
Open AccessRole of bronchoscopy in diagnosis of smear-negative pulmonary tuberculosis
- Open Access
- 20 August 2018
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 12 (3) , 370-372
Pericardial cyst masquerading as lung carcinoma
- 20 August 2018
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 12 (3) , 370-372
Open AccessPericardial cyst masquerading as lung carcinoma
- 16 July 2018
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 9 (3) , 51-54
Autonomic Dysfunction Manifesting as Severe Hypertension Following Cobra Envenomation: An Unusual Occurrence
Journal of Emergency Medicine Case Reports
- 16 July 2018
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 9 (3) , 51-54
Autonomic Dysfunction Manifesting as Severe Hypertension Following Cobra Envenomation: An Unusual Occurrence
Journal of Emergency Medicine Case Reports
- Open Access
- 1 January 2018
- Published by Medknow in Lung India
- Vol. 35 (5) , 449-+
Managing hemoptysis: What to do or what not to do?
Lung India, Official publication of the Indian Chest Society
- 1 January 2018
- Published by Medknow in Lung India
- Vol. 35 (5) , 449-+
Open AccessManaging hemoptysis: What to do or what not to do?
Lung India, Official publication of the Indian Chest Society
- Open Access
- 1 January 2018
- Published by Medknow in Journal of Family Medicine and Primary Care
- Vol. 7 (3) , 618-628
Spontaneous intracranial hemorrhage associated with dengue fever: An emerging concern for general physicians
Dengue fever (DF) is an arboviral disease caused by a positive-sense RNA virus of the genus Flavivirus. The overall incidence of DF has increased exponentially worldwide over the last three decades. The atypical clinical manifestations of DF grouped under expanded dengue syndrome (EDS), have also been reported more frequently for the last decade. These unusual manifestations are usually associated with coinfections, comorbidities, or complications of prolonged shock. Intracranial hemorrhage (ICH) is one of the rare manifestations of the central nervous system involvement by dengue as a part of EDS. The pathogenesis and treatment of this manifestation also remain controversial. Therefore, we report a case of a previously healthy 65-year-old female who developed ICH as a part of EDS along with a brief review of literature.
- 1 January 2018
- Published by Medknow in Journal of Family Medicine and Primary Care
- Vol. 7 (3) , 618-628
Open AccessSpontaneous intracranial hemorrhage associated with dengue fever: An emerging concern for general physicians
Dengue fever (DF) is an arboviral disease caused by a positive-sense RNA virus of the genus Flavivirus. The overall incidence of DF has increased exponentially worldwide over the last three decades. The atypical clinical manifestations of DF grouped under expanded dengue syndrome (EDS), have also been reported more frequently for the last decade. These unusual manifestations are usually associated with coinfections, comorbidities, or complications of prolonged shock. Intracranial hemorrhage (ICH) is one of the rare manifestations of the central nervous system involvement by dengue as a part of EDS. The pathogenesis and treatment of this manifestation also remain controversial. Therefore, we report a case of a previously healthy 65-year-old female who developed ICH as a part of EDS along with a brief review of literature.